Spyre Therapeutics Inc
SYRE
NASDAQ
Biotechnology
$103.63
USD
+1.78 (+1.75%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $8.97B
Volume 559.5K
Price Target
$112.00 – $135.00
USD
The 3 analysts offering 1-year price forecasts have a max estimate of $135.00 and a min estimate of $112.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$122.33
+$30.0 vs prior
Implied Upside
+18.0%
+28.9% vs prior
Analyst Covering
3
-8 vs prior period
Consensus
Buy
Declined vs prior
Signal Quality
Consensus Freshness
21%
Many ratings are older - consensus may be less current
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$2.33 Gap
Median $120.00 vs avg $122.33 - a few bullish outliers are pulling the average up
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
3 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
3 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Joseph Catanzaro | Piper Sandler | Buy | Maintained | 4 weeks ago | Plus | Plus | Plus |
David Hoang | Deutsche Bank | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Julian Harrison | BTIG | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
